Phibro Animal Health Corporation is recalling 61 units of NeoTerramycin 100/100D Type A Medicated Article sold in 50 lb. bags. This veterinary medication, containing the generic components neomycin and oxytetracycline, was found to have neomycin levels that did not meet potency specifications during stability testing. This defect means the product may not deliver the intended dosage, which can lead to ineffective treatment of health conditions in livestock. The recall specifically affects products distributed in Minnesota and Wisconsin under lot number A61370001NK.
The neomycin component in the medicated article was found to be 'out of specification,' which means the drug's strength may be lower than required for effective treatment. Using sub-potent medication can result in failed treatment of animal infections or the development of drug-resistant bacteria due to inadequate dosing.
Veterinary drug refund and professional consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response